Real Life Evaluation of Rheumatoid Arthritis in Canadians Taking HUMIRA (REACH)
Phase of Trial: Phase IV
Latest Information Update: 26 Feb 2016
At a glance
- Drugs Adalimumab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms REACH
- Sponsors Abbott Laboratories; AbbVie
- 23 Feb 2015 Status changed from active, no longer recruiting to completed according to ClinicalTrials.gov record.
- 26 Feb 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 29 Feb 2012 Planned end date changed from 1 Nov 2013 to 1 Mar 2015 as reported by ClinicalTrials.gov.